BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Vilana R, Bianchi L, Varela M, Nicolau C, Sánchez M, Ayuso C, García M, Sala M, Llovet JM, Bruix J. Is microbubble-enhanced ultrasonography sufficient for assessment of response to percutaneous treatment in patients with early hepatocellular carcinoma? Eur Radiol. 2006;16:2454-2462. [PMID: 16710666 DOI: 10.1007/s00330-006-0264-8] [Cited by in Crossref: 77] [Cited by in F6Publishing: 66] [Article Influence: 4.8] [Reference Citation Analysis]
Number Citing Articles
1 Koda M, Mandai M, Matono T, Sugihara T, Nagahara T, Ueki M, Ohyama K, Hosho K, Murawaki Y. Assessment of the ablated area after radiofrequency ablation by contrast-enhanced sonography; comparison with virtual sonography with magnetic navigation. Clinical Imaging 2010;34:60-4. [DOI: 10.1016/j.clinimag.2009.03.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
2 Ripollés T, Puig J. Actualización del uso de contrastes en ecografía. Revisión de las guías clínicas de la Federación Europea de Ecografía (EFSUMB). Radiología 2009;51:362-75. [DOI: 10.1016/j.rx.2009.05.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
3 Luo W, Numata K, Morimoto M, Oshima T, Ueda M, Okada M, Takebayashi S, Zhou X, Tanaka K. Role of Sonazoid-enhanced three-dimensional ultrasonography in the evaluation of percutaneous radiofrequency ablation of hepatocellular carcinoma. Eur J Radiol. 2010;75:91-97. [PMID: 19361941 DOI: 10.1016/j.ejrad.2009.03.021] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 2.2] [Reference Citation Analysis]
4 Hoeffel C, Pousset M, Timsit MO, Elie C, Méjean A, Merran S, Tranquart F, Khairoune A, Joly D, Richard S, Hélénon O, Correas JM. Radiofrequency ablation of renal tumours: diagnostic accuracy of contrast-enhanced ultrasound for early detection of residual tumour. Eur Radiol 2010;20:1812-21. [PMID: 20204642 DOI: 10.1007/s00330-010-1742-6] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 3.2] [Reference Citation Analysis]
5 Roccarina D, Garcovich M, Ainora ME, Riccardi L, Pompili M, Gasbarrini A, Zocco MA. Usefulness of contrast enhanced ultrasound in monitoring therapeutic response after hepatocellular carcinoma treatment. World J Hepatol 2015; 7(14): 1866-1874 [PMID: 26207168 DOI: 10.4254/wjh.v7.i14.1866] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
6 Kim YJ, Lee MW, Park HS. Small hepatocellular carcinomas: ultrasonography guided percutaneous radiofrequency ablation. Abdom Imaging 2013;38:98-111. [DOI: 10.1007/s00261-012-9883-5] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
7 Meloni MF, Smolock A, Cantisani V, Bezzi M, D'Ambrosio F, Proiti M, Lee F, Aiani L, Calliada F, Ferraioli G. Contrast enhanced ultrasound in the evaluation and percutaneous treatment of hepatic and renal tumors. Eur J Radiol 2015;84:1666-74. [PMID: 26094868 DOI: 10.1016/j.ejrad.2015.06.004] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 3.7] [Reference Citation Analysis]
8 de Nucci G, Della Corte C, Reati R, Imperatore N, Arena I, Larghi A, Manes G. Endoscopic ultrasound-guided radiofrequency ablation for hepatocellular carcinoma in cirrhosis: a case report test for efficacy and future perspectives. Endosc Int Open. 2020;8:E1713-E1716. [PMID: 33140029 DOI: 10.1055/a-1236-3105] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Nicolau C, Ripollés T. Contrast-enhanced ultrasound in abdominal imaging. Abdom Imaging 2012;37:1-19. [PMID: 21879317 DOI: 10.1007/s00261-011-9796-8] [Cited by in Crossref: 27] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
10 Minami Y, Nishida N, Kudo M. Therapeutic response assessment of RFA for HCC: Contrast-enhanced US, CT and MRI. World J Gastroenterol 2014; 20(15): 4160-4166 [PMID: 24764654 DOI: 10.3748/wjg.v20.i15.4160] [Cited by in CrossRef: 43] [Cited by in F6Publishing: 35] [Article Influence: 5.4] [Reference Citation Analysis]
11 Zheng SG, Xu HX, Lu MD, Xie XY, Xu ZF, Liu GJ, Liu LN. Role of contrast-enhanced ultrasound in follow-up assessment after ablation for hepatocellular carcinoma. World J Gastroenterol 2013; 19(6): 855-865 [PMID: 23430451 DOI: 10.3748/wjg.v19.i6.855] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
12 Bruix J, Reig M, Rimola J, Forner A, Burrel M, Vilana R, Ayuso C. Clinical decision making and research in hepatocellular carcinoma: pivotal role of imaging techniques. Hepatology. 2011;54:2238-2244. [PMID: 21932394 DOI: 10.1002/hep.24670] [Cited by in Crossref: 78] [Cited by in F6Publishing: 66] [Article Influence: 7.8] [Reference Citation Analysis]
13 Darnell A, Belmonte E, Reig M, Brú C. Evaluating the response to locoregional and systemic treatment for hepatocellular carcinoma. Radiologia (Engl Ed) 2018;60:424-36. [PMID: 30196841 DOI: 10.1016/j.rx.2018.05.004] [Reference Citation Analysis]
14 Hai Y, Savsani E, Chong W, Eisenbrey J, Lyshchik A. Meta-analysis and systematic review of contrast-enhanced ultrasound in evaluating the treatment response after locoregional therapy of hepatocellular carcinoma. Abdom Radiol (NY) 2021;46:5162-79. [PMID: 34410432 DOI: 10.1007/s00261-021-03248-9] [Reference Citation Analysis]
15 Choi D, Lim HK, Rhim H, Kim YS, Lee WJ, Paik SW, Koh KC, Lee JH, Choi MS, Yoo BC. Percutaneous radiofrequency ablation for early-stage hepatocellular carcinoma as a first-line treatment: long-term results and prognostic factors in a large single-institution series. Eur Radiol. 2007;17:684-692. [PMID: 17093964 DOI: 10.1007/s00330-006-0461-5] [Cited by in Crossref: 229] [Cited by in F6Publishing: 218] [Article Influence: 14.3] [Reference Citation Analysis]
16 Díaz-González Á, Vilana R, Bianchi L, García-Criado Á, Rimola J, Rodríguez de Lope C, Ferrer J, Ayuso C, Da Fonseca LG, Reig M, Forner A. Thermal Ablation for Intrahepatic Cholangiocarcinoma in Cirrhosis: Safety and Efficacy in Non-Surgical Patients. J Vasc Interv Radiol 2020;31:710-9. [PMID: 31685360 DOI: 10.1016/j.jvir.2019.06.014] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
17 Lencioni R, Della Pina C, Cioni D, Crocetti L. Guidelines for the use of contrast-enhanced ultrasound in hepatocellular carcinoma. European Journal of Cancer Supplements 2008;6:1-8. [DOI: 10.1016/j.ejcsup.2008.06.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
18 Palmieri VO, Santovito D, Marano G, Minerva F, Ricci L, D'Alitto F, Angelelli G, Palasciano G. Contrast-enhanced ultrasound in the diagnosis of hepatocellular carcinoma. Radiol Med 2015;120:627-33. [PMID: 25599661 DOI: 10.1007/s11547-014-0494-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
19 Andreano A, Galimberti S, Franza E, Knavel EM, Sironi S, Lee FT, Meloni MF. Percutaneous microwave ablation of hepatic tumors: prospective evaluation of postablation syndrome and postprocedural pain. J Vasc Interv Radiol 2014;25:97-105.e1-2. [PMID: 24286938 DOI: 10.1016/j.jvir.2013.09.005] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
20 Numata K, Luo W, Morimoto M, Kondo M, Kunishi Y, Sasaki T, Nozaki A, Tanaka K. Contrast enhanced ultrasound of hepatocellular carcinoma. World J Radiol 2010; 2(2): 68-82 [PMID: 21160920 DOI: 10.4329/wjr.v2.i2.68] [Cited by in CrossRef: 45] [Cited by in F6Publishing: 33] [Article Influence: 3.8] [Reference Citation Analysis]
21 Stride E, Tang M, Eckersley R. Physical phenomena affecting quantitative imaging of ultrasound contrast agents. Applied Acoustics 2009;70:1352-62. [DOI: 10.1016/j.apacoust.2008.10.003] [Cited by in Crossref: 43] [Cited by in F6Publishing: 23] [Article Influence: 3.3] [Reference Citation Analysis]
22 Guibal A, Bertin C, Egels S, Savier E, Grenier PA, Lucidarme O. Contrast-enhanced ultrasound (CEUS) follow-up after radiofrequency ablation or cryoablation of focal liver lesions: treated-area patterns and their changes over time. Eur Radiol. 2013;23:1392-1400. [PMID: 23138387 DOI: 10.1007/s00330-012-2702-0] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
23 Crocetti L, Della Pina C, Cioni D, Lencioni R. Peri-intraprocedural imaging: US, CT, and MRI. Abdom Imaging 2011;36:648-60. [DOI: 10.1007/s00261-011-9750-9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
24 Real M, Bianchi L, Vilana R, Burrel M, Rimola J. Tratamiento percutáneo e intraarterial del carcinoma hepatocelular. Radiología 2010;52:399-413. [DOI: 10.1016/j.rx.2010.05.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
25 Nishigori S, Numata K, Irie K, Fukuda H, Chuma M, Maeda S. Fusion imaging with contrast-enhanced ultrasonography for evaluating the early therapeutic efficacy of radiofrequency ablation for small hypervascular hepatocellular carcinomas with iso-echoic or unclear margins on conventional ultrasonography. J Med Ultrason (2001) 2018;45:405-15. [PMID: 29362966 DOI: 10.1007/s10396-018-0861-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
26 Jang JY, Kim MY, Jeong SW, Kim TY, Kim SU, Lee SH, Suk KT, Park SY, Woo HY, Kim SG, Heo J, Baik SK, Kim HS, Tak WY. Current consensus and guidelines of contrast enhanced ultrasound for the characterization of focal liver lesions. Clin Mol Hepatol. 2013;19:1-16. [PMID: 23593604 DOI: 10.3350/cmh.2013.19.1.1] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 4.4] [Reference Citation Analysis]
27 Pang EHT, Chan A, Ho SG, Harris AC. Contrast-Enhanced Ultrasound of the Liver: Optimizing Technique and Clinical Applications. AJR Am J Roentgenol. 2018;210:320-332. [PMID: 29220210 DOI: 10.2214/ajr.17.17843] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
28 Yu NC, Chaudhari V, Raman SS, Lassman C, Tong MJ, Busuttil RW, Lu DS. CT and MRI improve detection of hepatocellular carcinoma, compared with ultrasound alone, in patients with cirrhosis. Clin Gastroenterol Hepatol. 2011;9:161-167. [PMID: 20920597 DOI: 10.1016/j.cgh.2010.09.017] [Cited by in Crossref: 143] [Cited by in F6Publishing: 135] [Article Influence: 11.9] [Reference Citation Analysis]
29 Chan AK, Hegarty C, Klass D, Yoshida E, Chung S, Liu DM, Ho SG, Harris AC. The Role of Contrast-Enhanced Ultrasound in Guiding Radiofrequency Ablation of Hepatocellular Carcinoma. Can Assoc Radiol J 2015;66:171-8. [DOI: 10.1016/j.carj.2014.11.005] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
30 Wu H, Wilkins LR, Ziats NP, Haaga JR, Exner AA. Real-time monitoring of radiofrequency ablation and postablation assessment: accuracy of contrast-enhanced US in experimental rat liver model. Radiology 2014;270:107-16. [PMID: 23912621 DOI: 10.1148/radiol.13121999] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 4.1] [Reference Citation Analysis]
31 Luo W, Zhou X, He G, Li Q, Zheng X, Fan Z, Liu Q, Yu M, Han Z, Zhang J, Qian Y. Ablation of High Intensity Focused Ultrasound Combined with SonoVue on Rabbit VX2 Liver Tumors: Assessment with Conventional Gray-Scale US, Conventional Color/Power Doppler US, Contrast-Enhanced Color Doppler US, and Contrast-Enhanced Pulse-Inversion Harmonic US. Ann Surg Oncol 2008;15:2943-53. [DOI: 10.1245/s10434-008-0032-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
32 Chen M, Wu W, Yang W, Dai Y, Gao W, Yin S, Yan K. The Use of Contrast-Enhanced Ultrasonography in the Selection of Patients With Hepatocellular Carcinoma for Radio Frequency Ablation Therapy. Journal of Ultrasound in Medicine 2007;26:1055-63. [DOI: 10.7863/jum.2007.26.8.1055] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
33 Wong SN, Santi GE, Nurjadin H, Aguilar R, Gosalvez-Pe S. Temperature-dependent electrode repositioning for multiple overlapping radiofrequency ablation in ex vivo porcine livers. J Vasc Interv Radiol 2010;21:1733-8. [PMID: 20884231 DOI: 10.1016/j.jvir.2010.07.011] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
34 Fahey BJ, Nelson RC, Hsu SJ, Bradway DP, Dumont DM, Trahey GE. In vivo guidance and assessment of liver radio-frequency ablation with acoustic radiation force elastography. Ultrasound Med Biol. 2008;34:1590-1603. [PMID: 18471954 DOI: 10.1016/j.ultrasmedbio.2008.03.006] [Cited by in Crossref: 44] [Cited by in F6Publishing: 35] [Article Influence: 3.1] [Reference Citation Analysis]
35 Forner A, Ayuso C, Varela M, Rimola J, Hessheimer AJ, de Lope CR, Reig M, Bianchi L, Llovet JM, Bruix J. Evaluation of tumor response after locoregional therapies in hepatocellular carcinoma: are response evaluation criteria in solid tumors reliable? Cancer. 2009;115:616-623. [PMID: 19117042 DOI: 10.1002/cncr.24050] [Cited by in Crossref: 303] [Cited by in F6Publishing: 285] [Article Influence: 23.3] [Reference Citation Analysis]
36 Li S, Lin S, Cheng Y, Matsunaga TO, Eckersley RJ, Tang MX. Quantifying activation of perfluorocarbon-based phase-change contrast agents using simultaneous acoustic and optical observation. Ultrasound Med Biol 2015;41:1422-31. [PMID: 25656747 DOI: 10.1016/j.ultrasmedbio.2014.12.021] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
37 Bolondi L, Cillo U, Colombo M, Craxì A, Farinati F, Giannini EG, Golfieri R, Levrero M, Pinna AD, Piscaglia F, Raimondo G, Trevisani F, Bruno R, Caraceni P, Ciancio A, Coco B, Fraquelli M, Rendina M, Squadrito G, Toniutto P. Position paper of the Italian Association for the Study of the Liver (AISF): The multidisciplinary clinical approach to hepatocellular carcinoma. Digestive and Liver Disease 2013;45:712-23. [DOI: 10.1016/j.dld.2013.01.012] [Cited by in Crossref: 103] [Cited by in F6Publishing: 113] [Article Influence: 11.4] [Reference Citation Analysis]
38 Seror O, Lepetit-coiffé M, Le Bail B, de Senneville BD, Trillaud H, Moonen C, Quesson B. Real time monitoring of radiofrequency ablation based on MR thermometry and thermal dose in the pig liver in vivo. Eur Radiol 2008;18:408-16. [DOI: 10.1007/s00330-007-0761-4] [Cited by in Crossref: 45] [Cited by in F6Publishing: 39] [Article Influence: 3.0] [Reference Citation Analysis]
39 Ladam-Marcus V, Mac G, Job L, Piot-Veron S, Marcus C, Hoeffel C. [Contrast-enhanced ultrasound and liver imaging: review of the literature]. J Radiol 2009;90:93-106; quiz 107-8. [PMID: 19212278 DOI: 10.1016/s0221-0363(09)70087-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
40 Korcakova E, Mirka H, Liska V, Hosek P, Bajcurova K. Monitoring after radiofrequency ablation of liver tumors: contrast-enhanced ultrasound (CEUS) vs. contrast-enhanced computer tomography (CECT), two days after procedure. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2018. [PMID: 29790488 DOI: 10.5507/bp.2018.025] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
41 Xuan M, Zhou F, Ding Y, Zhu Q, Dong J, Zhou H, Cheng J, Jiang X, Wu P. Diagnostic accuracy of contrast-enhanced ultrasound in assessing the therapeutic response to radio frequency ablation for liver tumors: systematic review and meta-analysis. Surg Endosc 2018;32:2067-75. [DOI: 10.1007/s00464-017-5903-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
42 Rossi S, Ravetta V, Rosa L, Ghittoni G, Viera FT, Garbagnati F, Silini EM, Dionigi P, Calliada F, Quaretti P. Repeated radiofrequency ablation for management of patients with cirrhosis with small hepatocellular carcinomas: a long-term cohort study. Hepatology. 2011;53:136-147. [PMID: 20967759 DOI: 10.1002/hep.23965] [Cited by in Crossref: 106] [Cited by in F6Publishing: 100] [Article Influence: 8.8] [Reference Citation Analysis]
43 Nicolau Molina C, Fontanilla Echeveste T, Del Cura Rodríguez JL, Cruz Villalón F, Ripollés González T, Baudet Naveros B, Velasco Marcos MA, Garre Sánchez C, Huertas Arroyo R, Hernández García L. [Usefulness of contrast-enhanced ultrasonography in daily clinical practice: a multicenter study in Spain]. Radiologia. 2010;52:144-152. [PMID: 20044114 DOI: 10.1016/j.rx.2009.11.005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
44 Alzaraa A, Gravante G, Chung WY, Al-Leswas D, Morgan B, Dennison A, Lloyd D. Contrast-enhanced ultrasound in the preoperative, intraoperative and postoperative assessment of liver lesions. Hepatol Res 2013;43:809-19. [PMID: 23745715 DOI: 10.1111/hepr.12044] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
45 Szurowska E, Nowicki TK, Izycka-Swieszewska E, Zadrozny D, Markiet K, Studniarek M. Predictive value of apparent diffusion coefficient in evaluation of colorectal carcinoma hepatic metastases’ response to radiofrequency ablation. J Magn Reson Imaging. 2013;38:1027-1032. [PMID: 23526807 DOI: 10.1002/jmri.24089] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
46 Ju JX, Zeng QJ, Xu EJ, He XQ, Tan L, Huang QN, Li K, Zheng RQ. Intraprocedural contrast-enhanced ultrasound-CT/MR fusion imaging assessment in HCC thermal ablation to reduce local tumor progression: compared with routine contrast-enhanced ultrasound. Int J Hyperthermia 2019;36:785-93. [PMID: 31431086 DOI: 10.1080/02656736.2019.1640899] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
47 Jung E, Clevert D, Schreyer A, Schmitt S, Rennert J, Kubale R, Feuerbach S, Jung F. Evaluation of quantitative contrast harmonic imaging to assess malignancy of liver tumors: A prospective controlled two-center study. World J Gastroenterol 2007; 13(47): 6356-6364 [PMID: 18081224 DOI: 10.3748/wjg.v13.i47.6356] [Cited by in CrossRef: 43] [Cited by in F6Publishing: 44] [Article Influence: 2.9] [Reference Citation Analysis]
48 Zou X, Liu Q, Zhou X, He G, Yu M, Han Z, Meng X, Su H. Ultrasound-guided percutaneous laser and ethanol ablation of rabbit VX2 liver tumors. Acta Radiol. 2013;54:181-187. [PMID: 23482351 DOI: 10.1258/ar.2012.110723] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
49 Ishii T, Numata K, Hao Y, Doba N, Hara K, Kondo M, Tanaka K, Maeda S. Evaluation of hepatocellular carcinoma tumor vascularity using contrast-enhanced ultrasonography as a predictor for local recurrence following radiofrequency ablation. Eur J Radiol 2017;89:234-41. [PMID: 28034569 DOI: 10.1016/j.ejrad.2016.12.018] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
50 Surveillance group. ; Diagnosis group; Staging group; Surgery group; Local ablation group; TACE/TARE/HAI group; Target therapy/systemic therapy group; Radiotherapy group; Prevention group; Drafting group. Management consensus guideline for hepatocellular carcinoma: 2016 updated by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan. J Formos Med Assoc. 2018;117:381-403. [PMID: 29074347 DOI: 10.1016/j.jfma.2017.09.007] [Cited by in Crossref: 47] [Cited by in F6Publishing: 44] [Article Influence: 9.4] [Reference Citation Analysis]
51 Wang DC, Jang H, Kim TK. Characterization of Indeterminate Liver Lesions on CT and MRI With Contrast-Enhanced Ultrasound: What Is the Evidence? American Journal of Roentgenology 2020;214:1295-304. [DOI: 10.2214/ajr.19.21498] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 3.5] [Reference Citation Analysis]
52 Minami Y, Kudo M. Imaging Modalities for Assessment of Treatment Response to Nonsurgical Hepatocellular Carcinoma Therapy: Contrast-Enhanced US, CT, and MRI. Liver Cancer 2015;4:106-14. [PMID: 26697413 DOI: 10.1159/000367733] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 4.6] [Reference Citation Analysis]
53 Quaia E. Microbubble ultrasound contrast agents: an update. Eur Radiol 2007;17:1995-2008. [DOI: 10.1007/s00330-007-0623-0] [Cited by in Crossref: 247] [Cited by in F6Publishing: 194] [Article Influence: 16.5] [Reference Citation Analysis]
54 Sboros V, Tang MX. The assessment of microvascular flow and tissue perfusion using ultrasound imaging. Proc Inst Mech Eng H 2010;224:273-90. [PMID: 20349819 DOI: 10.1243/09544119JEIM621] [Cited by in Crossref: 32] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
55 Mauri G, Porazzi E, Cova L, Restelli U, Tondolo T, Bonfanti M, Cerri A, Ierace T, Croce D, Solbiati L. Intraprocedural contrast-enhanced ultrasound (CEUS) in liver percutaneous radiofrequency ablation: clinical impact and health technology assessment. Insights Imaging. 2014;5:209-216. [PMID: 24563244 DOI: 10.1007/s13244-014-0315-7] [Cited by in Crossref: 87] [Cited by in F6Publishing: 84] [Article Influence: 10.9] [Reference Citation Analysis]
56 Bolondi L, Correas JM, Lencioni R, Weskott HP, Piscaglia F. New perspectives for the use of contrast-enhanced liver ultrasound in clinical practice. Dig Liver Dis. 2007;39:187-195. [PMID: 17208526 DOI: 10.1016/j.dld.2006.08.008] [Cited by in Crossref: 55] [Cited by in F6Publishing: 52] [Article Influence: 3.7] [Reference Citation Analysis]
57 Nicolau C, Vilana R, Bianchi L, Brú C. Early-stage hepatocellular carcinoma: the high accuracy of real-time contrast-enhanced ultrasonography in the assessment of response to percutaneous treatment. Eur Radiol Suppl 2007;17:80-8. [DOI: 10.1007/s10406-007-0232-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
58 Del Cura JL, Del Cura G, Zabala R, Korta I. Contrast-enhanced ultrasonography to guide diagnostic and therapeutic interventional procedures. Radiologia (Engl Ed) 2021:S0033-8338(21)00067-9. [PMID: 33773773 DOI: 10.1016/j.rx.2021.02.005] [Reference Citation Analysis]
59 Marcus CD, Ladam-Marcus V, Cucu C, Bouché O, Lucas L, Hoeffel C. Imaging techniques to evaluate the response to treatment in oncology: current standards and perspectives. Crit Rev Oncol Hematol. 2009;72:217-238. [PMID: 18760935 DOI: 10.1016/j.critrevonc.2008.07.012] [Cited by in Crossref: 95] [Cited by in F6Publishing: 93] [Article Influence: 6.8] [Reference Citation Analysis]
60 Kondo T, Maruyama H, Sekimoto T, Shimada T, Takahashi M, Chiba T, Kanai F, Yokosuka O, Yamaguchi T. Natural history of postvascular-phase iso-enhanced lesions on the sonogram in chronic liver diseases. J Gastroenterol Hepatol 2014;29:165-72. [PMID: 24224484 DOI: 10.1111/jgh.12449] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
61 Bartolotta TV, Taibbi A, Midiri M, De Maria M. Hepatocellular cancer response to radiofrequency tumor ablation: contrast-enhanced ultrasound. Abdom Imaging. 2008;33:501-511. [PMID: 17786507 DOI: 10.1007/s00261-007-9294-1] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 2.3] [Reference Citation Analysis]
62 de la Serna S, Vilana R, Sánchez-Cabús S, Calatayud D, Ferrer J, Molina V, Fondevila C, Bruix J, Fuster J, García-Valdecasas JC. Results of laparoscopic radiofrequency ablation for HCC. Could the location of the tumour influence a complete response to treatment? A single European centre experience. HPB (Oxford). 2015;17:387-393. [PMID: 25545319 DOI: 10.1111/hpb.12379] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
63 Ooi CC, Low SC, Schneider-Kolsky M, Lombardo P, Lim SY, Abu Bakar R, Lo RH. Diagnostic accuracy of contrast-enhanced ultrasound in differentiating benign and malignant focal liver lesions: a retrospective study. J Med Imaging Radiat Oncol. 2010;54:421-430. [PMID: 20958940 DOI: 10.1111/j.1754-9485.2010.02195.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
64 Jung E, Uller W, Stroszczynski C, Clevert D. Kontrastmittelverstärkte Sonographie: Zur Therapiekontrolle von Radiofrequenzablation und transarterieller Chemoembolisation beim hepatozellulären Karzinom. Radiologe 2011;51:462-8. [DOI: 10.1007/s00117-010-2101-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
65 Wu H, Patel RB, Zheng Y, Solorio L, Krupka TM, Ziats NP, Haaga JR, Exner AA. Differentiation of benign periablational enhancement from residual tumor following radio-frequency ablation using contrast-enhanced ultrasonography in a rat subcutaneous colon cancer model. Ultrasound Med Biol 2012;38:443-53. [PMID: 22266229 DOI: 10.1016/j.ultrasmedbio.2011.12.008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
66 Nicolau Molina C, Fontanilla Echeveste T, Del Cura Rodríguez J, Cruz Villalón F, Ripollés González T, Baudet Naveros B, Velasco Marcos M, Garre Sánchez C, Huertas Arroyo R, Hernández García L, Pitti Reyes S, Gómez Rodríguez R, Calvo López M, Maroto Genover A, Álvarez Bustos G, Poch Zatarain M, Talegón Meléndez A. Usefulness of contrast-enhanced ultrasonography in daily clinical practice: A multicenter study in Spain. Radiología (English Edition) 2010;52:144-52. [DOI: 10.1016/s2173-5107(10)70011-2] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
67 Lepetit-coiffé M, Laumonier H, Seror O, Quesson B, Sesay M, Moonen CTW, Grenier N, Trillaud H. Real-time monitoring of radiofrequency ablation of liver tumors using thermal-dose calculation by MR temperature imaging: initial results in nine patients, including follow-up. Eur Radiol 2010;20:193-201. [DOI: 10.1007/s00330-009-1532-1] [Cited by in Crossref: 51] [Cited by in F6Publishing: 32] [Article Influence: 3.9] [Reference Citation Analysis]
68 Numata K, Fukuda H, Morimoto M, Kondo M, Nozaki A, Oshima T, Okada M, Takebayashi S, Maeda S, Tanaka K. Use of fusion imaging combining contrast-enhanced ultrasonography with a perflubutane-based contrast agent and contrast-enhanced computed tomography for the evaluation of percutaneous radiofrequency ablation of hypervascular hepatocellular carcinoma. Eur J Radiol. 2012;81:2746-2753. [PMID: 22197088 DOI: 10.1016/j.ejrad.2011.11.052] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 2.6] [Reference Citation Analysis]
69 Tateishi R, Shiina S, Ohki T, Sato T, Masuzaki R, Imamura J, Goto E, Goto T, Yoshida H, Obi S, Sato S, Kanai F, Yoshida H, Omata M. Treatment strategy for hepatocellular carcinoma: expanding the indications for radiofrequency ablation. J Gastroenterol 2009;44:142-6. [DOI: 10.1007/s00535-008-2247-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
70 Ayuso C, Rimola J, Forner A. [Imaging techniques in hepatocellular carcinoma: diagnosis, extension and evaluation of therapeutic response]. Gastroenterol Hepatol 2010;33:721-6. [PMID: 20447736 DOI: 10.1016/j.gastrohep.2010.01.012] [Reference Citation Analysis]